3.77 USD
0 (0%)
3.8855 USD
+0.12 (+3.06%)
LFMD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. The financial health of LFMD is average, but there are quite some concerns on its profitability. LFMD is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- LFMD had negative earnings in the past year.
- LFMD had a positive operating cash flow in the past year.
- LFMD had negative earnings in each of the past 5 years.
- In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
- LFMD has a Return On Assets (-11.68%) which is comparable to the rest of the industry.
- Looking at the Return On Equity, with a value of -586.53%, LFMD is doing worse than 85.71% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 5.81%, LFMD belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROIC | 5.81% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- LFMD has a better Operating Margin (0.27%) than 62.86% of its industry peers.
- LFMD's Gross Margin of 86.96% is amongst the best of the industry. LFMD outperforms 91.43% of its industry peers.
- In the last couple of years the Gross Margin of LFMD has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
- LFMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- LFMD has more shares outstanding than it did 1 year ago.
- LFMD has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, LFMD has an improved debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of 0.00, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of LFMD (0.00) is comparable to the rest of the industry.
- There is no outstanding debt for LFMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 0 |
ROIC/WACC0.57
WACC10.23%
2.3 Liquidity
- A Current Ratio of 0.73 indicates that LFMD may have some problems paying its short term obligations.
- With a Current ratio value of 0.73, LFMD is not doing good in the industry: 82.86% of the companies in the same industry are doing better.
- LFMD has a Quick Ratio of 0.73. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
- LFMD has a worse Quick ratio (0.66) than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 78.13% over the past year.
- LFMD shows a strong growth in Revenue. In the last year, the Revenue has grown by 30.71%.
- LFMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.23% yearly.
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
3.2 Future
- LFMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.36% yearly.
- Based on estimates for the next years, LFMD will show a small growth in Revenue. The Revenue will grow by 3.16% on average per year.
EPS Next Y61.09%
EPS Next 2Y45.21%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- A Price/Forward Earnings ratio of 64.28 indicates a quite expensive valuation of LFMD.
- The rest of the industry has a similar Price/Forward Earnings ratio as LFMD.
- LFMD is valuated expensively when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 64.28 |
4.2 Price Multiples
- 77.14% of the companies in the same industry are more expensive than LFMD, based on the Enterprise Value to EBITDA ratio.
- LFMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 734.77 | ||
| EV/EBITDA | 13.47 |
4.3 Compensation for Growth
- LFMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- LFMD's earnings are expected to grow with 34.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.21%
EPS Next 3Y34.41%
5. Dividend
5.1 Amount
- LFMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
3.77
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-17 2025-11-17/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners43.01%
Inst Owner Change-0.01%
Ins Owners17.81%
Ins Owner Change4.76%
Market Cap181.49M
Revenue(TTM)252.34M
Net Income(TTM)-7.71M
Analysts81.43
Price Target9.44 (150.4%)
Short Float %12.76%
Short Ratio3.86
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-40.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-341.17%
Min EPS beat(2)-635.29%
Max EPS beat(2)-47.05%
EPS beat(4)2
Avg EPS beat(4)-125.48%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-71.45%
EPS beat(12)4
Avg EPS beat(12)-68.84%
EPS beat(16)5
Avg EPS beat(16)-56.76%
Revenue beat(2)0
Avg Revenue beat(2)-6.5%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)-4.95%
Revenue beat(4)2
Avg Revenue beat(4)-0.06%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.29%
Revenue beat(12)7
Avg Revenue beat(12)-0.23%
Revenue beat(16)7
Avg Revenue beat(16)-1.53%
PT rev (1m)0%
PT rev (3m)-28.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.04%
EPS NY rev (1m)0%
EPS NY rev (3m)-50.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-6.47%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 64.28 | ||
| P/S | 0.72 | ||
| P/FCF | 734.77 | ||
| P/OCF | 13.82 | ||
| P/B | 138.08 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.47 |
EPS(TTM)-0.14
EYN/A
EPS(NY)0.06
Fwd EY1.56%
FCF(TTM)0.01
FCFY0.14%
OCF(TTM)0.27
OCFY7.23%
SpS5.24
BVpS0.03
TBVpS-0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.68% | ||
| ROE | -586.53% | ||
| ROCE | 7.35% | ||
| ROIC | 5.81% | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 0.27% | ||
| PM (TTM) | N/A | ||
| GM | 86.96% | ||
| FCFM | 0.1% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 116.91% | ||
| Cap/Sales | 5.1% | ||
| Interest Coverage | 0.33 | ||
| Cash Conversion | 112.17% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.73 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 0 |
F-Score5
WACC10.23%
ROIC/WACC0.57
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y61.09%
EPS Next 2Y45.21%
EPS Next 3Y34.41%
EPS Next 5Y18.36%
Revenue 1Y (TTM)30.71%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%12.7%
Revenue Next Year15.11%
Revenue Next 2Y4.37%
Revenue Next 3Y8.63%
Revenue Next 5Y3.16%
EBIT growth 1Y103.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year237.85%
EBIT Next 3Y55.58%
EBIT Next 5Y43.22%
FCF growth 1Y103.53%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y1051.68%
OCF growth 3YN/A
OCF growth 5Y133.93%
LIFEMD INC / LFMD FAQ
What is the ChartMill fundamental rating of LIFEMD INC (LFMD) stock?
ChartMill assigns a fundamental rating of 4 / 10 to LFMD.
What is the valuation status for LFMD stock?
ChartMill assigns a valuation rating of 3 / 10 to LIFEMD INC (LFMD). This can be considered as Overvalued.
What is the profitability of LFMD stock?
LIFEMD INC (LFMD) has a profitability rating of 3 / 10.
How financially healthy is LIFEMD INC?
The financial health rating of LIFEMD INC (LFMD) is 4 / 10.